Testosterone cypionate is FDA-approved for male hypogonadism at doses of 50 to 400 mg every two to four weeks [4]
Findings, published in the journal Obesity, showed that individuals lost an average of 8.7% of baseline body weight after 1 year of treatment, compared to the 14.9% to 20.9% weight reductions demonstrated in phase 3 clinical trials with the glucagon-like peptide-1 (GLP-1)-based receptor agonists
Results seem to back up this notion, with Mounjaro achieving an average weight loss of 22.5% at the highest dose after 72 weeks
In the first 3 months, paid advertising typically drives the fastest results while your medical weight loss program builds organic visibility
Ferroptosis: mechanisms and links with diseases
Baseline labs including thyroid, metabolic panel, and hormone levels to ensure your program is safe and precisely calibrated